MR

Manish Rukhadbhai Vasoya

Active Director Director DIN 11283441
DIN 11283441 First appointment Sep 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Manish Rukhadbhai Vasoya

Data last updated:

Manish Rukhadbhai Vasoya is a Director at Medixis Biosciences Private Limited (since 2025). The company operates in Biotechnology.

DIN 11283441
Primary Designation Director
Industry Biotechnology
First Appointment 06 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medixis Biosciences Private Limited U47890GJ2025PTC167333
Director06 Sep 20252025Active

Board colleagues of Manish Rukhadbhai Vasoya

NameDINCompanyDesignation
Govind Nathabhai Vasoya11283442Medixis Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medixis Biosciences Private Limited
Premium access

Shareholding and investment profile for Manish Rukhadbhai Vasoya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manish Rukhadbhai Vasoya

Manish Rukhadbhai Vasoya currently holds 1 directorship: Medixis Biosciences Private Limited (Director, since 06 Sep 2025).

Manish Rukhadbhai Vasoya was first appointed on 06 Sep 2025 as Director at Medixis Biosciences Private Limited.

The current boards of Manish Rukhadbhai Vasoya's companies include Govind Nathabhai Vasoya (Medixis Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available